Form 4 for KLRS Kalaris Therapeutics, Inc.

Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-04 · accession 0000899243-21-039356 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-10-05	2021-10-04	KLRS	Melian Agustin	Chief Medical Off	S - Sale	$23.91	-18.7K	456.8K	-4%	-$446.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-10-04	S	D	10,678	$23.29	461,540	D	—	—	(F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.78 to $23.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
2	Common	Common Stock	2021-10-04	S	D	333	$26.02	453,529	D	—	—	(F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.795 to $26.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
3	Common	Common Stock	2021-10-04	S	D	2,967	$25.41	453,862	D	—	—	(F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.78 to $25.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
4	Common	Common Stock	2021-10-04	S	D	4,711	$24.23	456,829	D	—	—	(F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.78 to $24.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.